| 郭冬梅,谈维,林洁.基于经济一体化背景的京津冀国家级高新技术开发区医药产业集群竞争优势分析[J].中国药事,2020,34(5):556-563 |
| 基于经济一体化背景的京津冀国家级高新技术开发区医药产业集群竞争优势分析 |
| Analysis of Competitive Advantages of Pharmaceutical Industry Clusters in the Beijing-Tianjin-Hebei National High-tech Development Zone Based on the Background of Economic Integration |
| 投稿时间：2019-10-27 |
| DOI：10.16153/j.1002-7777.2020.05.009 |
| 中文关键词: 京津冀 国家高新区 医药产业集群 竞争优势 |
| 英文关键词: Beijing-Tianjin-Hebei pharmaceutical industry cluster national high-tech zone competitive advantages |
| 基金项目:北京市社会科学基金项目（编号17YJB017） |
|
| 摘要点击次数: 1081 |
| 全文下载次数: 186 |
| 中文摘要: |
| 目的： 概述京津冀一体化发展的宏观战略背景下，医药产业集群的整合和协同化发展的趋势，以及国家高新区是政府规划的产业园区的典型代表。方法： 梳理了京津冀三地国家高新区中医药产业集群的情况，确定竞争优势评价对象。从产业价值链的视角，分别采用GEMM模型和相对比较优势指数、从绝对优势和比较优势两个方面对京津冀典型国家高新区的竞争优势进行综合分析。结果与结论： 京津冀三地以高新区为代表的政府主导型医药产业集群发展水平较高、竞争优势较强。北京的竞争优势远大于天津、河北，并且在全国具有数一数二的绝对竞争优势；北京和天津高新区医药产业集群在研发环节具有较大优势，且北京大于天津，河北则在生产、流通环节具有比较优势。政府和园区建设管理单位要立足比较优势，加强规划和引导，医药产业集群的建设发展要依据各自不同的差别化定位。 |
| 英文摘要: |
| Objective: The paper summarized the context of the macro-strategy of the integrated development of Beijing-Tianjin-Hebei, the integration and coordinated development of the pharmaceutical industry cluster being an inevitable trend. National High-tech Zone is a typical representative of the government-planned industrial parks. Methods: The development of the Chinese pharmaceutical industry clusters in the National High-tech Zone of Beijing, Tianjin and Hebei is analyzed, and the evaluation target of competitive advantage is determined. From the perspective of industrial value chain, the GEM model and the revealed comparative advantage indexes are used to comprehensively analyze the competitive advantages of Beijing, Tianjin and Hebei typical high-tech zones from two aspects:absolute advantage and comparative advantage. Results and conclusion: It shows that the government-led pharmaceutical industry cluster represented by the high-tech zone in Beijing, Tianjin and Hebei has a high level of development and strong competitive advantage. Beijing's competitive advantage is far greater than that of Tianjin and Hebei, and it has one of the best absolute competitive advantages in the country.The pharmaceutical industry clusters in Beijing and Tianjin High-tech Zone have comparative advantages in research and development, and Beijing is larger than Tianjin. Hebei has comparative advantages in production and circulation. The government and the park construction management unit should strengthen the planning and guidance based on their comparative advantages. The construction and development of the pharmaceutical industry clusters should be based on their different differentiated positioning. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |